You just read:

Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive Non-small Cell Lung Cancer

News provided by

Merrimack Pharmaceuticals, Inc.

Oct 30, 2017, 06:55 ET